TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...

Explore Rivian Automotive production, R2 rollout, commercial vans, connected technology, manufacturing expansion, and ...

Factory-Trained Technician Reveals Why Most Lift Kit Installations Fail Within 12 Months O'Fallon, United States - July ...

While monsoon patterns change, Indian farming is still stuck in yesterday’s assumptions, writes Jaideep Hardikar ...

Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...

CITY OF INDUSTRY, CA, UNITED STATES, June 29, 2026 /EINPresswire.com/ -- During formulation trials in a pharmaceutical ...

Issued on behalf of Conexeu Sciences Inc.A sector analysis of regenerative medicine — the science of restoring tissue rather than merely ...

Forgent Power Solutions (FPS) stock is up 119% YTD on AI data center demand, but lofty valuation signals 32% downside.

Ever since COVID-19 highlighted to the world the dependence of our daily lives on supply chains, resilience is at the ...

Abstract: Pantograph arc has become a potential hazard for the safe running of electric locomotives. It is essential to build an accurate mathematical model of pantograph arc for arc simulation.

Background Despite progress in reducing global maternal mortality in recent decades, low- and lower-middle-income countries ...

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...